About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 757490, 9 pages
http://dx.doi.org/10.1155/2013/757490
Research Article

Targeted Resequencing Reveals ALK Fusions in Non-Small Cell Lung Carcinomas Detected by FISH, Immunohistochemistry, and Real-Time RT-PCR: A Comparison of Four Methods

1Department of Pathology, Haartman Institute, University of Helsinki, P.O. Box 21 (Haartmaninkatu 3), 00014 Helsinki, Finland
2Department of Pathology, HUSLAB, Helsinki University Central Hospital, P.O. Box 400, 00029 HUS, Finland
3Division of Pulmonary Medicine, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, P.O. Box 340, 00029 HUS, Finland
4Lab21 Ltd, 184 Cambridge Science Park, Cambridge CB4 0GA, UK
5Technology Centre, Institute for Molecular Medicine Finland (FIMM), University of Helsinki, P.O. Box 20, 00014 Helsinki, Finland

Received 19 September 2012; Accepted 9 December 2012

Academic Editor: Akanchha Kesari

Copyright © 2013 Katja Tuononen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Chiarle, C. Voena, C. Ambrogio, R. Piva, and G. Inghirami, “The anaplastic lymphoma kinase in the pathogenesis of cancer,” Nature Reviews Cancer, vol. 8, no. 1, pp. 11–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Soda, Y. L. Choi, M. Enomoto et al., “Identification of the transforming EML4-ALK fusion gene in non-small cell lung cancer,” Nature, vol. 448, no. 7153, pp. 561–566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. P. Koivunen, C. Mermel, K. Zejnullahu et al., “EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer,” Clinical Cancer Research, vol. 14, no. 13, pp. 4275–4283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. U. McDermott, A. J. Iafrate, N. S. Gray et al., “Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors,” Cancer Research, vol. 68, no. 9, pp. 3389–3395, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. L. Kwak, Y. J. Bang, D. R. Camidge et al., “Anaplastic lymphoma kinase inhibition in non-small cell lung cancer,” The New England Journal of Medicine, vol. 363, no. 18, pp. 1693–1703, 2010. View at Publisher · View at Google Scholar
  6. A. T. Shaw, B. Y. Yeap, B. J. Solomon et al., “Effect of crizotinib on overall survival in patients with advanced non-small cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis,” The Lancet Oncology, vol. 12, no. 11, pp. 1004–1012, 2011. View at Publisher · View at Google Scholar
  7. K. Rikova, A. Guo, Q. Zeng et al., “Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer,” Cell, vol. 131, no. 6, pp. 1190–1203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Takeuchi, L. C. Young, Y. Togashi et al., “KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer,” Clinical Cancer Research, vol. 15, no. 9, pp. 3143–3149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Togashi, M. Soda, S. Sakata et al., “KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only,” PLoS ONE, vol. 7, no. 2, Article ID e31323, 2012. View at Publisher · View at Google Scholar
  10. C. Meldrum, M. A. Doyle, and R. W. Tothill, “Next-generation sequencing for cancer diagnostics: a practical perspective,” The Clinical Biochemist Reviews, vol. 32, no. 4, pp. 177–195, 2011.
  11. A. M. Sulonen, P. Ellonen, H. Almusa et al., “Comparison of solution-based exome capture methods for next generation sequencing,” Genome Biology, vol. 12, no. 9, p. R94, 2011. View at Publisher · View at Google Scholar
  12. H. Li and R. Durbin, “Fast and accurate long-read alignment with Burrows-Wheeler transform,” Bioinformatics, vol. 26, no. 5, pp. 589–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Li, B. Handsaker, A. Wysoker et al., “The sequence Alignment/Map format and SAMtools,” Bioinformatics, vol. 25, no. 16, pp. 2078–2079, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Ye, M. H. Schulz, Q. Long, R. Apweiler, and Z. Ning, “Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads,” Bioinformatics, vol. 25, no. 21, pp. 2865–2871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Krzywinski, J. Schein, I. Birol et al., “Circos: an information aesthetic for comparative genomics,” Genome Research, vol. 19, no. 9, pp. 1639–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. T. Robinson, H. Thorvaldsdóttir, W. Winckler et al., “Integrative genomics viewer,” Nature Biotechnology, vol. 29, no. 1, pp. 24–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. L. Wallander, K. B. Geiersbach, S. R. Tripp, and L. J. Layfield, “Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing,” Archives of Pathology & Laboratory Medicine, vol. 136, no. 7, pp. 796–803, 2012. View at Publisher · View at Google Scholar
  18. P. A. Just, A. Cazes, A. Audebourg et al., “Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: a comprehensive study of Caucasian non-smokers,” Lung Cancer, vol. 76, no. 3, pp. 309–315, 2012. View at Publisher · View at Google Scholar
  19. A. McLeer-Florin, D. Moro-Sibilot, A. Melis, D. Salameire, C. Lefebvre, F. Ceccaldi, et al., “Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a french study,” Journal of Thoracic Oncology, vol. 7, no. 2, pp. 348–354, 2012. View at Publisher · View at Google Scholar
  20. J. H. Paik, C. M. Choi, H. Kim et al., “Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma,” Lung Cancer, vol. 76, no. 3, pp. 403–409, 2012.
  21. T. Sasaki, S. J. Rodig, L. R. Chirieac, and P. A. Jänne, “The biology and treatment of EML4-ALK non-small cell lung cancer,” European Journal of Cancer, vol. 46, no. 10, pp. 1773–1780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Rowley, “Chromosome translocations: dangerous liaisons revisited,” Nature Reviews Cancer, vol. 1, no. 3, pp. 245–250, 2001. View at Scopus
  23. M. Nambiar, V. Kari, and S. C. Raghavan, “Chromosomal translocations in cancer,” Biochimica et Biophysica Acta, vol. 1786, no. 2, pp. 139–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Perner, P. L. Wagner, F. Demichelis et al., “EML4-ALK fusion lung cancer: a rare acquired event,” Neoplasia, vol. 10, no. 3, pp. 298–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Martelli, G. Sozzi, L. Hernandez et al., “EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues,” American Journal of Pathology, vol. 174, no. 2, pp. 661–670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. T. Shaw, B. Y. Yeap, M. Mino-Kenudson et al., “Clinical features and outcome of patients with non-small cell lung cancer who harbor EML4-ALK,” Journal of Clinical Oncology, vol. 27, no. 26, pp. 4247–4253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. W. S. Wong, E. L. H. Leung, K. K. T. So et al., “The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS,” Cancer, vol. 115, no. 8, pp. 1723–1733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Inamura, K. Takeuchi, Y. Togashi et al., “EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset,” Modern Pathology, vol. 22, no. 4, pp. 508–515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Zhang, S. Zhang, X. Yang et al., “Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression,” Molecular Cancer, vol. 9, article 188, 2010. View at Publisher · View at Google Scholar · View at Scopus